For the quarter ending 2025-09-30, UCLE had $7,418 increase in cash & cash equivalents over the period.
| Cash Flow | 2025-09-30 | 2025-03-31 |
|---|---|---|
| Depreciation and amortization | 720 | 360 |
| Issuance of common stock for compensation and services | 525,789 | 56,100 |
| Issuance of common stock for debt | 8,333 | - |
| Accounts receivable | 68,959 | -290,413 |
| Note receivable | 7,770 | - |
| Inventories | -45,598 | 214,107 |
| Prepaid | 0 | -10,000 |
| Accounts payable | -42,410 | -3,630 |
| Accrued liabilities | -23,375 | 54,553 |
| Customer deposits | -130,917 | - |
| Net loss | -60,444 | -560,232 |
| Incentive expense | 24,000 | - |
| Financing costs | 0 | - |
| Debt discount amortization | - | 0 |
| Loss on deconsolidation | 0 | - |
| Issuance of warrants for services | - | -394,999 |
| Deferred revenue | - | 0 |
| Accounts payable - related parties | 0 | 0 |
| Customer deposits | - | -120,942 |
| Accrued compensation - officers | 0 | 0 |
| Net cash used in operating activities | -3,492 | -92,486 |
| Net borrowings (repayments) under lines of credit | 100,000 | 0 |
| Proceeds from issuance of note payable shareholder | 78,300 | - |
| Repayments of note payable shareholder | 42,135 | 31,865 |
| Proceeds from notes payable | 38,000 | 12,000 |
| Repayments of notes payable | 126,430 | 0 |
| Treasury stock | 7,425 | - |
| Proceeds from issuance of common stock | 0 | 50,000 |
| Cash dividends paid | 29,400 | - |
| Net cash provided by financing activities | 10,910 | 30,135 |
| Employee advance | 0 | - |
| Note receivable | 0 | 0 |
| Net cash used in investing activities | 0 | 0 |
| Net increase (decrease) in cash | 7,418 | -62,351 |
| Cash and cash equivalents at beginning of period | 130,840 | - |
| Cash and cash equivalents at end of period | 75,907 | - |
US NUCLEAR CORP. (UCLE)
US NUCLEAR CORP. (UCLE)